First, to back up for a second: GLP-1 (glucagon-like peptide-1) is a hormone produced by the gut which promotes insulin release, reduces appetite, and communicates with the reward centers in the brain
Associate research fellow Benjamin Bonenti, who is part of the UQ team that researches the harm of some peptides, said the testing revealed a "big problem"
Discuss potential alternative medications if weight gain persists despite lifestyle efforts Seeking medical guidance is a proactive step, not a failure
You might also experience reemergence of food noise, or intrusive thoughts about food and increased appetite, says Kushner
Patent Expiration Timeline Novo Nordisk holds multiple patents on semaglutide covering the compound itself, formulations, delivery methods, and manufacturing processes
Tirzepatide, a newer dual GLP-1 and GIP receptor agonist, shows enhanced weight loss compared to semaglutide alone in clinical trials